Drug Shortage Report for TEVA-LACTULOSE

Last updated on 2017-10-10 History
Report ID 19964
Drug Identification Number 02331551
Brand name TEVA-LACTULOSE
Common or Proper name LACTULOSE
Company Name TEVA CANADA LIMITED
Active Ingredient(s) LACTULOSE
Strength(s) 667MG
Dosage form(s) SOLUTION
Route of administration ORAL
Packaging size 20
ATC code A06AD
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-20
Estimated end date 2017-09-30
Actual end date 2017-10-06
Shortage status Resolved
Updated date 2017-10-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-10-10 French Compare
v6 2017-10-10 English Compare
v5 2017-09-19 French Compare
v4 2017-09-19 English Compare
v3 2017-08-21 French Compare
v2 2017-08-21 English Compare
v1 2017-08-21 English Compare